Mepolizumab for chronic rhinosinusitis with nasal polyps

被引：6

作者：

Brusselle, Guy G. ^{[1
,2
,3
]}

Gevaert, Philippe ^{[4
]}

机构：

[1] Ghent Univ Hosp, Dept Resp Med, B-9000 Ghent, Belgium

[2] Erasmus Univ, Med Ctr, Dept Epidemiol, Rotterdam, Netherlands

[3] Erasmus Univ, Med Ctr, Dept Resp Med, Rotterdam, Netherlands

[4] Univ Ghent, Dept Otorhinolaryngol, Ghent, Belgium

来源：

LANCET RESPIRATORY MEDICINE | 2021年 / 9卷 / 10期

关键词：

D O I：

10.1016/S2213-2600(21)00133-8

中图分类号：

R4 [临床医学];

学科分类号：

1002 ; 100602 ;

摘要：

引用

页码：1081 / 1082

页数：2

共 9 条

[1] Efficacy and safety of dupilumab in patients with severe chronic rhinosinusitis with nasal polyps (LIBERTY NP SINUS-24 and LIBERTY NP SINUS-52): results from two multicentre, randomised, double-blind, placebo-controlled, parallel-group phase 3 trials [J].

Bachert, Claus ;

Han, Joseph K. ;

Desrosiers, Martin ;

Hellings, Peter W. ;

Amin, Nikhil ;

Lee, Stella E. ;

Mullol, Joaquim ;

Greos, Leon S. ;

Bosso, John V. ;

Laidlaw, Tanya M. ;

Cervin, Anders U. ;

Maspero, Jorge F. ;

Hopkins, Claire ;

Olze, Heidi ;

Canonica, G. Walter ;

Paggiaro, Pierluigi ;

Cho, Seong H. ;

Fokkens, Wytske J. ;

Fujieda, Shigeharu ;

Zhang, Mei ;

Lu, Xin ;

Fan, Chunpeng ;

Draikiwicz, Steven ;

Kamat, Siddhesh A. ;

Khan, Asif ;

Pirozzi, Gianluca ;

Patel, Naimish ;

Graham, Neil M. H. ;

Ruddy, Marcella ;

Staudinger, Heribert ;

Weinreich, David ;

Stahl, Neil ;

Yancopoulos, George D. ;

Mannent, Leda P. .

LANCET, 2019, 394 (10209) :1638-1650

[2]

Fokkens W J., 2020, Rhinology

[3] Efficacy and safety of omalizumab in nasal polyposis: 2 randomized phase 3 trials [J].

Gevaert, Philippe ;

Omachi, Theodore A. ;

Corren, Jonathan ;

Mullol, Joaquim ;

Han, Joseph ;

Lee, Stella E. ;

Kaufman, Derrick ;

Ligueros-Saylan, Monica ;

Howard, Monet ;

Zhu, Rui ;

Owen, Ryan ;

Wong, Kit ;

Islam, Lutaf ;

Bachert, Claus .

JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY, 2020, 146 (03) :595-605

[4] Mepolizumab for chronic rhinosinusitis with nasal polyps (SYNAPSE): a randomised, double-blind, placebo-controlled, phase 3 trial [J].

Han, Joseph K. ;

Bachert, Claus ;

Fokkens, Wytske ;

Desrosiers, Martin ;

Wagenmann, Martin ;

Lee, Stella E. ;

Smith, Steven G. ;

Martin, Neil ;

Mayer, Bhabita ;

Yancey, Steven W. ;

Sousa, Ana R. ;

Chan, Robert ;

Hopkins, Claire .

LANCET RESPIRATORY MEDICINE, 2021, 9 (10) :1141-1153

[5] Severe eosinophilic asthma with nasal polyposis: A phenotype for improved sinonasal and asthma outcomes with mepolizumab therapy [J].

Howarth, Peter ;

Chupp, Geoffrey ;

Nelsen, Linda M. ;

Bradford, Eric S. ;

Bratton, Daniel J. ;

Smith, Steven G. ;

Albers, Frank C. ;

Brusselle, Guy ;

Bachert, Claus .

JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY, 2020, 145 (06) :1713-+

[6]

Ortega Hector, 2014, Ann Am Thorac Soc, V11, P1011, DOI 10.1513/AnnalsATS.201312-454OC

[7] Mepolizumab Treatment in Patients with Severe Eosinophilic Asthma [J].

Ortega, Hector G. ;

Liu, Mark C. ;

Pavord, Ian D. ;

Brusselle, Guy G. ;

FitzGerald, J. Mark ;

Chetta, Alfredo ;

Humbert, Marc ;

Katz, Lynn E. ;

Keene, Oliver N. ;

Yancey, Steven W. ;

Chanez, Pascal .

NEW ENGLAND JOURNAL OF MEDICINE, 2014, 371 (13) :1198-1207

[8] Inflammatory endotypes of chronic rhinosinusitis based on cluster analysis of biomarkers [J].

Tomassen, Peter ;

Vandeplas, Griet ;

Van Zele, Thibaut ;

Cardell, Lars-Olaf ;

Arebro, Julia ;

Olze, Heidi ;

Foerster-Ruhrmann, Ulrike ;

Kowalski, Marek L. ;

Olszewska-Ziaber, Agnieszka ;

Holtappels, Gabriele ;

De Ruyck, Natalie ;

Wang, Xiangdong ;

Van Drunen, Cornelis ;

Mullol, Joaquim ;

Hellings, Peter ;

Hox, Valerie ;

Toskala, Elina ;

Scadding, Glenis ;

Lund, Valerie ;

Zhang, Luo ;

Fokkens, Wytske ;

Bachert, Claus .

JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY, 2016, 137 (05) :1449-+

[9] Functions of tissue-resident eosinophils [J].

Weller, Peter F. ;

Spencer, Lisa A. .

NATURE REVIEWS IMMUNOLOGY, 2017, 17 (12) :746-760

← 1 →